Drawing for IMPACT

USPTO serial 99138400

IMPACT

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
MILLER, CHARLES FREDERICK
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with IMPACT?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Kristen Ruisi

Kristen Ruisi Venable LLP151 West 42nd Street, 49th FloorNew York, NY 10036United States

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for the treatment of blood-borne pathogens and diseases caused thereby; pharmaceutical preparations for the treatment of viruses, bacteria and other pathogenic organisms and diseases caused therebyACTIVE—
010Medical devices for use in treating infections caused by antimicrobial resistant microorganisms, namely, bacterial meningitis, Methicillin-resistant Staphylococcus aureus, salmonella, whooping cough, Legionnaires' disease, Boils and cellulitis, impetigo, necrotizing fasciitis, staph infections, E.coli, Clostridioides difficile, listeriosis, urinary tract infections, sexually transmitted infections, ear infections, tuberculosis, lyme disease, tetanus, bacterial vaginosis, plague; medical devices for use in treating sepsisACTIVE—
042Providing medical and scientific research information in the field of health and pharmaceuticals on the internet; Research and development of new products for others; Research and development services, namely conducting research focused on the fight against antimicrobial resistance (AMR) and for the treatment of blood-borne pathogens and diseasesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Oct 5, 2026MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Oct 5, 2026ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Mar 3, 2026NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jan 6, 2026NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jan 6, 2026PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 31, 2025NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Dec 10, 2025CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Nov 19, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 19, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 19, 2025ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Aug 19, 2025GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Aug 19, 2025GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Aug 19, 2025CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jul 2, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jul 2, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 2, 2025TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 30, 2025GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 30, 2025GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 30, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 30, 2025DOCKASSIGNED TO EXAMINER—
Apr 15, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 15, 2025MAFRAPPLICATION FILING RECEIPT MAILED—
Apr 15, 2025NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance